Personalized lifestyle changes delivered via instant messaging for adults with pre-hypertension
Instant Message-delivered Personalised Lifestyle Modification Intervention for Pre-hypertension Management Among Community Dwelling Adults: a Randomised Controlled Trial
NA · The University of Hong Kong · NCT06504849
This study is testing if sending personalized health tips through instant messaging can help Chinese adults with pre-hypertension make better lifestyle choices to lower their blood pressure.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 256 (estimated) |
| Sex | All |
| Sponsor | The University of Hong Kong (other) |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT06504849 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a personalized lifestyle modification intervention delivered through instant messaging for managing pre-hypertension among Chinese adults. Participants with systolic blood pressure between 120-139 mmHg or diastolic blood pressure between 80-89 mmHg will receive tailored messages aimed at promoting healthier lifestyle choices. The intervention focuses on non-pharmacological approaches to lower blood pressure and prevent the progression to hypertension. The study aims to raise awareness of pre-hypertension and encourage proactive management through technology.
Who should consider this trial
Good fit: Ideal candidates are Chinese adults aged 18 and older with pre-hypertension who can read and communicate in Chinese and use mobile instant messaging.
Not a fit: Patients with a history of hypertension, cardiovascular diseases, or those currently undergoing other blood pressure reduction interventions may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the risk of developing hypertension in at-risk adults through effective lifestyle changes.
How similar studies have performed: Previous studies have shown that lifestyle modification interventions can effectively manage blood pressure, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Systolic BP 120-139 or diastolic BP 80-89mmHg. The BP screening procedures and requirements (i.e., office BP measurement and ABPM) will strictly follow the International Society of Hypertension's Global Hypertension Practice Guidelines; 2. Aged ≥18 years; 3. Able to read and communicate in Chinese; and 4. Able to use mobile phone instant messaging function. Exclusion Criteria: 1. Ever diagnosis of HTN; 2. Ever diagnosis of cardiovascular diseases (CVDs); 3. Pregnant or \<3-month post-partum; 4. Current diagnosis of psychiatric disease or currently taking a psychotropic drug; and 5. Currently participating in any type of BP reduction intervention.
Where this trial is running
Hong Kong
- University of Hong Kong — Hong Kong, Hong Kong (RECRUITING)
Study contacts
- Study coordinator: Jung Jae Lee
- Email: leejay@hku.hk
- Phone: +852 3917 6971
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pre-hypertension, Lifestyle Modification, Blood Pressure Management, Mobile Phone Use